Quarterly report pursuant to Section 13 or 15(d)

SHARE-BASED COMPENSATION

v3.23.3
SHARE-BASED COMPENSATION
9 Months Ended
Sep. 30, 2023
SHARE-BASED COMPENSATION  
SHARE-BASED COMPENSATION

NOTE 5 – SHARE-BASED COMPENSATION

In April 2021, the board of directors approved the creation of the 2021 Equity Incentive Plan (the “Plan”). The Plan became effective as of the completion of the corporate conversion, with an annual evergreen provision pursuant to the Plan. The Plan currently reserves an aggregate of 2,874,063 shares of common stock, subject to adjustments as provided in the Plan, of which 485,868 are currently still available for issuance as of September 30, 2023. The purpose of the Plan is to attract, retain and incentivize directors, officers, employees, and consultants.

In June 2021, the Company granted stock options to purchase a total of 807,500 shares of common stock to its three executives and three non-employee management team members to replace the Class B Membership Interests that were cancelled in March 2021. The options were issued at an exercise price of $6.26, with the employee options vesting 40% upon issuance and the balance over 36 months, and the non-employee options vesting at grant date. The Company recorded general and administrative expenses of $181,720 and $545,160 for the three and nine months ended September 30, 2023 and 2022, respectively, related to compensation expense for these options.

In July 2021, the Company granted stock options to purchase a total of 1,550,000 shares of common stock to its three executives pursuant to their respective employment agreements, the independent directors, and one consultant, pursuant to the Plan. The options were issued at an exercise price of $6.18, the grant date fair value, with one-quarter of the executive’s options vesting upon issuance and the balance over 36 months, and the options granted to the directors and consultants vesting over 36 months. The Company recorded general and administrative expenses of $490,916 and $1,472,750 for each of the three and nine months ended September 30, 2023 and 2022, respectively, related to compensation expense for these options.

In January 2022, the Company granted stock options to purchase a total of 80,000 shares of common stock to seven consultants pursuant to the Plan. The options were issued at an exercise price of $4.44, the grant date fair value, with one-quarter of the options vesting upon issuance and the balance over 36 months. The Company recorded general and administrative expenses of $18,950 for the three months ended September 30, 2023 and 2022, respectively, and $56,850 and $126,333 for the nine months ended September 30, 2023 and 2022, respectively, related to compensation expense for these options.

In April 2022, the Company granted stock options to purchase a total of 30,000 shares of common stock to a new employee pursuant to the Plan. The options were issued at an exercise price of $3.79, the grant date fair value, with one-quarter of the options vesting upon issuance and the balance over 36 months. The Company recorded general and administrative expenses of $5,378 for the three months ended September 30, 2023 and 2022, respectively, and $16,133 and $30,473 for nine months ended September 30, 2023 and 2022, respectively, related to compensation expense for these options.

In February 2023, the Company granted stock options to purchase a total of 467,500 shares of common stock to its four employees and seven consultants pursuant to the Plan. The options were issued at an exercise price of $3.41, the grant date fair value, with the options vesting monthly over 36 months. The Company recorded general and administrative expenses of $109,521 and $255,549 for the three and nine months ended September 30, 2023, respectively, related to compensation expense for these options.

In June 2023, the Company granted stock options to purchase a total of 50,000 shares of common stock to its five independent board of directors pursuant to the Plan. The options were issued at an exercise price of $2.75, the grant date fair value, with the options vesting on the one-year anniversary of the grant date. The Company recorded general and administrative expenses of $26,800 for the three and nine months ended September 30, 2023, respectively related to compensation expense for these options.

Compensation expense associated with these awards is recognized over the vesting period based on the fair value of the option at the grant date determined based on the Black-Scholes model. Option valuation models require the input of highly subjective assumptions including the expected price volatility. The Company’s employee stock options have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the fair value computation using the Black-Scholes option pricing model. Because there is no public market for the Company’s stock options and very little historical experience with the Company’s stock, similar public companies were used for the comparison of volatility and the dividend yield. The risk-free rate of return was derived from U.S. Treasury notes with comparable maturities.

The Company determined the fair value of the option awards using the Black-Scholes option pricing model using the following weighted average assumptions:

Nine Months Ended

 

    

September 30, 2023

 

Expected term

 

6.90

years

Volatility

 

98

%

Dividend yield

 

%

Risk-free interest rate

 

3.85

%

Weighted average grant date fair value

$

2.75

A summary of the Company’s stock option activity is as follows:

Nine Months Ended

    

Weighted Average

    

September 30, 2023

    

Exercise Price

Outstanding at the beginning of the period

 

2,467,500

 

$

6.12

Granted

 

517,500

3.35

Exercised

 

Forfeited

Outstanding at the end of the period

2,985,000

5.64

Exercisable

2,091,861

$

6.02

The total non-cash compensation expense for these options not yet recognized as of September 30, 2023 was $3,292,136. The weighted average vesting period for the unvested options is 1.46 years. The intrinsic value of the stock options at September 30, 2023 was $0 with a remaining weighted average contractual life of 8.06 years. The Company records the impact of any forfeitures of options as they occur.